Features

TTBD aims to bring together inventors, investors and industry

The OHSU Technology Transfer & Business Development (TTBD) office is trying to send a clear message: We’ve got some really cool inventions at OHSU, and we’re open for business. Two new articles from the Portland Business Journal have focused on the TTBD office and the importance of commercializing innovations coming out of universities. The first article titled “OHSU conferences aim to bring together inventors, investors and industry,” discussed the office’s efforts to give investors and industry … Read More

Science on the set: New video highlights research at OHSU

Just who are the scientists of OHSU? A newly released video shows us they are innovators, groundbreakers, and pioneers. They embrace an entrepreneurial spirit and work together in a state-of-the-art scientific environment. They are bold. They are creative. They care. These extraordinary individuals are the behind-the-scenes brilliance of OHSU. In just 2 ½ minutes, the video not only shares OHSU’s scientific backstory but highlights the forward-thinking, collaborative environment that makes this a world-class place for … Read More

Research courtyard: Construction project starting soon

The third phase of the North Campus Utility Plant project behind Richard Jones Hall is expected to begin Saturday, Nov. 8, and continue in stages into the new year. The work includes positioning a crane in the research courtyard, lifting materials and equipment over the top of RJH, and installing supports and cooling towers on the backside of RJH and the Vollum Institute. If you work in the affected areas or have visitors, impacts may … Read More

Letters of Intent for OCTRI biomedical innovation program due Nov. 12

The Oregon Clinical & Translational Research Institute (OCTRI) is now accepting letters of intent to apply for its Biomedical Innovation Program. The program cultivates and selects promising translational projects that develop new biomedical devices, diagnostics, and software with the objective of moving innovative technologies to clinical application, making a meaningful impact on human health. Deadline: Letters of intent due Nov. 12, 2014 Amount: Up to $40,000 over one year Eligibility: Principal investigators must fit OHSU eligibility … Read More

Nomination deadline for Gruber Genetics and Neuroscience Prizes is Dec. 15

Genetics Prize The unrestricted $500,000 prize is presented to a leading scientist, or group of scientists (up to three), in recognition of groundbreaking contributions to any realm of genetics research. These contributions may include original discoveries in genetic function, regulation, transmission, and variation, as well as in genomic organization. Nominations may be submitted by individuals, organizations, and institutions that are active in or have an appreciation for contemporary genetic research or problems. Neuroscience Prize This … Read More

Winter deadlines for American Heart research grants and fellowships

The American Heart Association has announced its winter deadlines for a wide range of funding opportunities relating to cardiovascular disease and stroke. All proposals and applications will be due either January 15th or 22nd, 2015. American Heart Association – Winter 2015 Funding Opportunities Pre-Doctoral Fellowship – $25,000 per year for one or two years to help students begin careers in cardiovascular or stroke related  research by providing research assistance and training. Research should be broadly related … Read More

Orexigen featured in the Portland Business Journal

You may have read that a drug from an OHSU startup received FDA approval last month. In 2003, OHSU’s office of Technology Transfer & Business Development (TTBD) created a start-up company called Orexigen Therapeutics, Inc., with Michael Cowley, then a neuroscience researcher at the Oregon National Primate Research Center. Cowley’s work looks at the appetite-regulating pathways in the brain and how these pathways are affected by obesity. Orexigen Therapeutics became public in 2007, and now the … Read More

OHSU startup Orexigen earns FDA approval

The office of Technology Transfer and Business Development is happy to announce that a drug from  Orexigen Therapeutics Inc., called Contrave, has been approved by the FDA. This drug helps with weight management, along with a reduced-calorie diet and increased physical activity, in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) who also have at least one weight-related comorbid condition. Contrave has two components: … Read More

Additional new faculty join OHSU School of Dentistry

The OHSU School of Dentistry welcomes a number of new faculty members this month. Dean Phillip Marucha, D.M.D., Ph.D., with the support of the provost’s office, is increasing the number of dental faculty, with the goal of having a six-to-one student-to-faculty ratio on the predoctoral clinic floor. “Our faculty needs are very important right now,” said Dr. Marucha. “We want to take care of the full- and part-time faculty we have currently, by rewarding them for their hard work … Read More

New faculty at OHSU School of Dentistry

The OHSU School of Dentistry welcomes a number of new faculty members this month. According to Dean Phillip Marucha, D.M.D., Ph.D., the dental school has received funding from the provost’s office to increase dental faculty, with the goal of having a six-to-one student-to-faculty ratio on the predoctoral clinic floor. “Our faculty needs are very important right now,” said Dr. Marucha. “We want to take care of the full- and part-time faculty we have currently, by rewarding them for their … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives